共 34 条
[1]
Brown, Imam, Recent studies on doxorubicin and its analogues, Progress in medicinal chemistry, 21, pp. 169-236, (1984)
[2]
Crooke, Duvernay, Mong, Molecular pharmacology of anthracyclines, Molecular actions and targets for cancer chemotherapeutic agents, pp. 137-162, (1981)
[3]
DiMarco, Adriamycin: the therapeutic activity on experimental tumors, International symposium on adriamycin, pp. 53-63, (1972)
[4]
Keating, McCredie, Bodey, Smith, Gehan, Freirieich, Improved prospects for long-term survival in adults with acute myelogenous leukemia, J. Am. Med. Assoc., 248, pp. 2481-2486, (1982)
[5]
Bernard, Weill, Boiron, Jacquillat, Flandrin, Gemon, Acute promyelocytic leukemia: results of treatment by daunorubicin, Blood, 41, pp. 489-496, (1973)
[6]
Swenerton, Legha, Smith, Hortobagyi, Gehan, Yap, Gutterman, Blumenschein, Prognostic factors in metastatic breast cancer treated with combination chemotherapy, Cancer Res., 39, pp. 1552-1562, (1979)
[7]
Young, Lippman, De Vita, Bull, Torney, Perspectives in the treatment of breast cancer, Ann. Intern. Med., 86, (1976)
[8]
Ozols, Young, Speyer, Phase I and pharmacological studies of adriamycin administered intraperitoneally to patients with ovarian cancer, Cancer Res., 42, pp. 4265-4269, (1982)
[9]
Evan, Feld, DeBoer, Osoba, Curtis, Baker, Myers, Quirt, Pritchard, Brown, Kutas, Blackstein, Ottema, Millband, Cyclophosphamide, doxorubicin, and cis-platin in the treatment of non-small cell bronchogenic carcinoma, Cancer Treat. Rep., 65, pp. 947-954, (1981)
[10]
Knight, Lagakos, Stolbach, Colsky, Horton, Israel, Benett, Perlia, Regelson, Carbone, Adriamycin in the treatment of far-advanced lung cancer, Cancer Treat. Rep., 60, pp. 939-941, (1976)